Bwx Technologies Inc Stock Price, News & Analysis

BWX Technologies (BWXT) has agreed to acquire L3Harris' Aerojet Ordnance Tennessee (A.O.T.) business for approximately $100 million. A.O.T., which generated revenue of about $40 million in the trailing twelve months, is the sole provider of depleted uranium to the U.S. government and manufactures specialized materials including tungsten, molybdenum, and various alloys. The acquisition, expected to close by year-end, will enhance BWXT's capabilities in advanced materials manufacturing for commercial, military, and space applications. The deal is anticipated to be slightly accretive to BWXT's earnings within 12-18 months, excluding purchase accounting and one-time costs.

BWX Technologies (BWXT) has signed an agreement to acquire L3Harris' Aerojet Ordnance Tennessee (A.O.T.) business for approximately $100 million. A.O.T., which generated revenue of about $40 million in the trailing twelve months, is the sole provider of depleted uranium to the U.S. government and manufactures specialized materials including tungsten, molybdenum, and various alloys. The acquisition is expected to close by year-end and become slightly accretive to BWXT's earnings within 12-18 months, excluding purchase accounting and one-time costs. The business will operate within BWXT's government operations segment.

BWX Technologies (NYSE: BWXT) has announced the opening of the John D. Haynes School of Welding Technology at Mount Vernon High School in Indiana. The company, along with the U.S. Navy and BlueForge Alliance, invested $500,000 in the facility, which can accommodate up to 60 students annually. The program offers students a dual-track opportunity to complete their high school degree while obtaining professional welding certification, leading to direct employment opportunities at BWXT's Nuclear Operations Group. The initiative aims to address critical training needs for national defense priorities and may serve as a blueprint for similar programs nationwide.

BWX Technologies, Inc. (NYSE: BWXT) announces that Hanford Tank Waste Operations & Closure, (H2C) has been approved by the U.S. Department of Energy (DOE) to begin the Hanford Integrated Tank Disposition Contract (ITDC). The DOE issued H2C a notice to proceed, effective October 21, 2024. H2C is a joint venture led by a BWXT subsidiary and includes Amentum and Fluor companies. The contract was awarded earlier in 2024, and a protest against this award was recently dismissed in the U.S. Court of Federal Claims.

The ITDC scope includes operation of Hanford tank farm facilities, eventual operation of the Waste Treatment and Immobilization Plant, and responsibility for other core functions such as project management, security and emergency services, business performance, and environment, safety, health and quality. H2C's leadership team brings 170 years of combined experience in tank waste disposition and disciplined nuclear operations.

BWX Technologies, Inc. (NYSE: BWXT) announced that its subsidiary, Nuclear Fuel Services, Inc. (NFS), has been selected by the U.S. Department of Energy (DOE) as one of the successful bidders for High-Assay Low-Enriched Uranium (HALEU) deconversion services. This selection is aimed at supporting the civil advanced reactor marketplace.

The contract is an indefinite-delivery, indefinite-quantity agreement, with future orders to be solicited by the DOE from the awarded companies, including NFS. The minimum ordering guarantee for this contract is set at $2 million. The DOE is expected to release additional information about this award on October 8 at 5:30 p.m. E.T.

BWX Technologies (NYSE: BWXT) has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024, after the market closes. The company will host a conference call at 5:00 p.m. EST on the same day to discuss the results.

Investors and analysts can participate in the call using the following dial-in numbers:

• U.S.: 1-888-596-4144
• International: 1-646-968-2525
• Conference ID: 4276735

A live webcast and supporting presentation will be available on the company's website at www.bwxt.com/investors. A replay of the call will also be accessible on the BWXT website for a time.

BWX Technologies, Inc. (NYSE: BWXT), parent company of Nuclear Fuel Services (NFS), has announced a $100,000 donation to the Unicoi County United Way to support recovery efforts in Erwin, Tennessee following Hurricane Helene. The contribution will aid emergency response teams in providing essential supplies, medical aid, shelter, and long-term recovery services.

BWXT CEO Rex Geveden expressed solidarity with the Erwin community, where NFS has been operating since 1957. The company is also facilitating employee donations and organizing volunteer efforts to assist in the recovery process. NFS, a part of BWXT's Nuclear Operations Group, processes highly enriched uranium for naval nuclear reactors and provides uranium downblending services.

BWX Technologies (NYSE: BWXT) has been awarded a contract by the National Nuclear Security Administration (NNSA) to conduct a yearlong engineering study for the Domestic Uranium Enrichment Centrifuge Experiment (DUECE) program. The study aims to evaluate options for deploying a centrifuge pilot plant to establish domestic uranium enrichment capabilities for national security purposes.

The contract, awarded to BWXT subsidiary Nuclear Fuel Services, Inc., represents the next phase of the DUECE program. The objective is to inform the acquisition approach for a pilot plant that will demonstrate centrifuge performance, reliability, and life-cycle costs for the NNSA. Fluor will serve as the engineering, procurement, and construction service provider for this activity.

This initiative aligns with BWXT's strategy to expand its role in the national security nuclear fuel cycle, leveraging its unique nuclear operations infrastructure and NRC Category 1 uranium handling and processing licenses.

BWX Technologies, Inc. (NYSE: BWXT) has appointed Vittorio Puppo as president of BWXT Medical , effective August 12, 2024. Puppo brings over 30 years of experience in imaging, nuclear medicine, radiation therapy, and biotech. He previously served as COO of Radiopharm Theranostics and held various positions at Bracco, including chief marketing and strategy officer.

Puppo succeeds Jonathan Cirtain, who will transition back to his role as BWXT's chief development officer. BWXT Medical manufactures custom radiopharmaceuticals, radiotherapies, and medical isotopes in Ottawa and at TRIUMF's commercial cyclotron facility. The company aims to deliver high-quality nuclear medical products and solutions to improve patient outcomes worldwide.